Ledger.Open graph →

SEC Form D · Amendment · filed July 28, 2021

Coeptis Therapeutics Inc

Offering

$6.0M

Sold

$5.2M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WEXFORD, PA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

David Mehalick · Wexford, PAExec · Director Michael Handley · Wexford, PADirector Daniel Yerace · Wexford, PAExec · Director Christine Sheehy · Wexford, PAExec · Director Chip Sa Gomes · Sydney, New South Wales, Channel IslandsExec · Director Edward Cataldo · Laurel, MTExec · Director Philippe Santin · Senningerberg, LuxembourgExec · Director Richard Galvin · Sydney, New South Wales, Channel IslandsDirector Justin Cobb · Miami, FLDirector Cody Shandraw · Miami, FLExec · Director Cory Jones · Miami, FLExec · Director Ray Harari · Miami, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗